Send me a link:

*Text messaging rates may apply.

 Dow Down 1.33% Nasdaq Down 1.57%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
3.05 Down 0.05(1.61%) 2:00PM EDT - Nasdaq Real Time Price
Prev Close:3.10
Open:3.06
Bid:3.04 x 3500
Ask:3.05 x 1300
1y Target Est:10.00
Beta:2.4
Next Earnings Date:N/A
Day's Range:3.03 - 3.12
52wk Range:2.75 - 5.50
Volume:55,005
Avg Vol (3m):129,467
Market Cap:69.16M
P/E (ttm):N/A
EPS (ttm):-0.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCDown 1.61%69.16M
AZNDown 0.19%92.12B
JNJDown 1.27%285.74B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):55.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.13
Quarterly EPS Est (Jun-14) :-0.30
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback